Physician profile
Stephen S Lee
NPI 1194883991
$7,772.21
in general payments reported to CMS, 2019-2025
17 companies · $20.53 in 2025
The $20.53 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,142 · 2020: $735 · 2021: $800 · 2022: $552 · 2023: $316 · 2024: $207 · 2025: $20.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,297.71 | 2019-2023 | Repatha |
| Amarin Pharma, INC. | $524.00 | 2019-2021 | |
| Medtronic Vascular, INC. | $378.84 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $338.01 | 2019-2021 | |
| Davol INC. | $296.67 | 2021-2023 | Arista Ah Flexitip |
| Pfizer INC. | $248.49 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.55 | 2019-2022 | |
| Medtronic, INC. | $158.36 | 2024 | Cobalt Dr Mri Surescan |
| Insmed, INC. | $81.68 | 2019 | |
| Glaxosmithkline, LLC. | $60.04 | 2023-2024 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $39.94 | 2022 | |
| Arbor Pharmaceuticals, INC. | $33.80 | 2019 | |
| Abbott Laboratories | $31.87 | 2021 | |
| Novo Nordisk INC | $25.26 | 2019-2020 | |
| Sanofi Pasteur INC. | $24.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $21.48 | 2022 | |
| Bardy Diagnostics, INC. | $17.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.